Beyond Today: Advances in Psychiatry Clinics -South Eastern Division Spring Conference 2024

'Beyond Today: Advances in Psychiatry Clinics'

This year’s conference provides psychiatrists with a fantastic opportunity to explore emerging themes in clinical psychiatry such as advances in rTMS, psychedelics in treatment, diagnosis and treatment of cognitive disorders.

This event will be taking place online via Zoom. The event will be recorded and available to watch on demand for 60 days so you can catch up at a time more convenient for you.

Event programme

Keep a look out on our Twitter/X account for up-to-date information: @RCPsychSE.

Professor Rob Howard – New investigations and treatments for dementia

Dr Jeremy Isaacs – Functional Cognitive Disorder I am a consultant neurologist at Kingston Hospital and St George’s Hospital, where I am a member of the multi-disciplinary cognitive neurology service. From 2019-2024 I was Clinical Director of the NHS London Dementia Clinical Network where I oversaw a regional quality improvement programme and led the first national memory service audit. In April 2024 I was appointed National Clinical Director for Dementia and Older People’s Mental Health.

I was a member of the RCPsych young onset dementia services working group and the NICE 2018 dementia guideline committee and chaired the NICE self-harm guideline committee.

I am honorary reader in neurology at St George’s, University of London where I co-direct the MSc in Clinical Neuroscience Practice and am director of the Neurosciences Clinical Academic Group.

My research interests are in functional cognitive disorders and in clinical trials in Alzheimer’s disease and vascular dementia.

Dr Graham Campbell – Psychedelics in Psychiatry: Where are we now?
Graham worked for eight years as a consultant psychiatrist at Mill View Hospital in Brighton and Hove. He is interested in neuroscience and psychotherapy. He completed an MSc in Neuroscience from KCL/IoP and trained with the Imperial College Psychedelic Research Group to work as an assistant psychedelic guide on the psilocybin vs escitalopram depression trial.

He has helped organise and facilitate psychedelic integration groups in Brighton since 2019 and has worked as an associate editor for an edition of Frontiers in Psychiatry on the potential clinical application of psychedelics.

He is a member of the Advisory Council with The Institute of Psychedelic Therapy (IPT) and co-chairs ‘Academic Circle’ discussion groups for IPT members/affiliates.

In 2020, he left the NHS to work full-time as a trial psychiatrist and psychedelic guide for Small Pharma and Imperial College’s dimethyltryptamine (DMT)-assisted psychotherapy trials for depression. Phase I and Phase IIa trials have now been completed. Graham helped develop a therapist training programme for the DMT trials, having co-produced the psychedelic therapy framework. He is currently working in private practice in Brighton and Hove.

Dr Mohamed Abdelghani – Recent Advances in rTMS

Dr Abdelghani currently serves as the Immediate Past President of the Clinical TMS Society (CTMSS), the largest TMS medical society worldwide. The society is dedicated to optimising clinical practices, raising awareness, and enhancing accessibility to Transcranial Magnetic Stimulation (TMS) therapy. In 2022 he became the first person from outside the USA to be elected as president of the society. Before that, he held various leadership positions in the CTMSS, including Vice-President and Secretary, and has been a member of the Board of Directors since 2017.

He is a founding member of the Foundation for Advancement of Clinical TMS (FACTMS) and currently serves on its board. Additionally, he holds the position of Chair of the Clinics Expansion Committee within FACTMS.

In 2016, Dr. Abdelghani founded the first clinical TMS service in the NHS in London at Camden and Islington NHS Foundation Trust, and he continues to lead this service. He has worked as a Consultant Psychiatrist in the NHS since 2013 and specifically as a consultant psychiatrist at Camden and Islington NHS Foundation Trust in Central London since 2014. He has received two clinical excellence awards from the Trust for his contributions to improving NHS services and providing high-quality care.

Dr Abdelghani is actively involved in TMS clinical research with the goal of enhancing the efficiency and accessibility of TMS treatment for different patient groups. He served as the London Principal Investigator for the BRIGhTMIND TMS Randomised Control Trial (RCT), the largest TMS clinical trial conducted in the UK.

Divisional Poster Prize

Open to all SAS Doctors, Higher Trainees ST4-6 and Core Trainees CT1-3 working in the South Eastern Division who are Specialist Associates, Affiliates, PMPTs or members of the Royal College of Psychiatrists.

You are invited to submit a poster and abstract on any area of psychiatry.

A limited number of posters will be chosen to be displayed at the Spring Conference and the abstract printed in the Programme and Abstracts Booklet.  Posters must not exceed 750 mm x 1000 mm - portrait. 

A maximum of 20 posters will be considered for pre-judging and these will be allocated on a first-come-first-served basis. Only one poster may be submitted per applicant.

Please ensure you read all the regulations before making a submission.

Closing date for submissions: Wednesday 17 April

Rules and regulations and entry form

Foundation Year and Medical Student Poster Prize

Open to all Foundation Year doctors and medical students working or studying in the South Eastern Division who are Affiliates or Members of the Royal College of Psychiatrists.

You are invited to submit a poster and abstract on any area of psychiatry.

A limited number of posters will be chosen to be displayed at the Spring Conference and the abstract printed in the Programme and Abstracts booklet.  Posters must not exceed 750 mm x 1000 mm - portrait.

A maximum of 20 posters will be considered for pre-judging and these will be allocated on a first-come-first-served basis.  Only one poster may be submitted per applicant.

Please ensure you read all the regulations before making a submission.

Closing date for submissions: Wednesday 17 April

The top 4 posters from both categories will be chosen to give a 5 minute presentation at the conference on 8 May 2024 online.

Rules and regulations, and entry form

Read our terms and conditions for event bookings prior to booking the webinar.

Please kindly note, all sessions will be recorded. The recordings are distributed via email with a specific link and passcode. These are emailed out within 1 week of the event. Please do not schedule CPD time expecting to receive the recording link the same day as the live event.

We would encourage those who register to attend on the day of the event, should they wish to ask questions to our speakers.

All recordings are sent out to delegates via the email address used at the time of registering. If you are unsure whether your email address is up to date, please update this via your membership account. We will not confirm this with you and it is your responsibility to make sure it is correct.